Evidence map›Paper›PMID 34245111›Full record

ArticleThe Kaohsiung journal of medical sciences2021

Hsa-circ_0000064 accelerates the malignant progression of gastric cancer via sponging microRNA-621.

Ayiguli Hare, Min Zeng, Aizimaiti Rehemutula, Shi-Kun Su, Hai-Feng Wang

Open access · goldAbstract read
In one paragraph

Article in The Kaohsiung journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ayiguli HareDepartment of Chest and Abdominal Radiotherapy, Affiliated Tumor Hospital of Xinjiang Medical University, Xinjiang, Urumqi, China.
Min ZengDepartment of Chest and Abdominal Radiotherapy, Affiliated Tumor Hospital of Xinjiang Medical University, Xinjiang, Urumqi, China.
Aizimaiti RehemutulaDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Xinjiang, Urumqi, China.
Shi-Kun SuDepartment of Chest and Abdominal Radiotherapy, Affiliated Tumor Hospital of Xinjiang Medical University, Xinjiang, Urumqi, China.
Hai-Feng WangDepartment of Chest and Abdominal Radiotherapy, Affiliated Tumor Hospital of Xinjiang Medical University, Xinjiang, Urumqi, China.ORCID https://orcid.org/0000-0003-3461-402X
Xinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) is one of the most common digestive system tumors in the world. Many circular RNAs (circRNAs) are involved in the progression of GC. The purpose of this study was to delve into the expression characteristics and biological functions of circ_0000064 in GC, and further study its mechanisms. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to detect circ_0000064 expression in 61 GC tissues and cell lines. Circ_0000064 knockdown was successfully modeled with siRNA. The effects of circ_0000064 on the biological functions of GC cells were analyzed by CCK-8, BrdU, and Transwell assays. Bioinformatics and dual-luciferase reporter gene assay were adopted to explore the relations between circ_0000064 and microRNA-621 (miR-621). Western blot was used to examine the regulatory function of circ_0000064 and miR-621 on SYF2 pre-mRNA splicing factor 2. Cric_0000064 expression was elevated in GC tissues and cell lines. Knocking down cric_0000064 could inhibit the viability, migration, and invasion of GC cells. Dual-luciferase reporter gene assay showed that miR-621 could bind circ_0000064 and SYF2 3'UTR; in addition, miR-621 overexpression or SYF2 knockdown could partially weaken the cancer-promoting effect of circ_0000064 on GC cells. Circ_0000064 expression was negatively correlated with miR-621 expression in GC tissues while positively with SYF2 expression. Circ_0000064 can participate in the GC progression via modulating miR-621/SYF2 axis. This implies that circ_0000064 may be a new diagnosed biomarker or a new therapeutic target of GC.

Indexed as

Biomarkers, TumorBlotting, WesternCell Line, TumorCell ProliferationDisease ProgressionFemaleGene Expression Regulation, NeoplasticHEK293 CellsHumansMaleMicroRNAsMiddle AgedReal-Time Polymerase Chain ReactionRNA-Binding ProteinsRNA, CircularStomach NeoplasmsBiomarkers, TumorGCIP-interacting protein p29, humanMicroRNAsMIRN621 microRNA, humanRNA-Binding ProteinsRNA, Circularcric_0000064GCmiR-621SYF2

Identifiers

PMID34245111
PMCPMC11896383
OpenAlexW3182148611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.